The last time I discussed Nuvo Research, the company's lead product Pennsaid -a topical non-steroidal anti-inflammatory drug - was still about a month away from a commerical launch in the United States. Pennsaid was approved in November of last year and US partner Mallinckrodt Inc., a Covidien subsi...
